Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?

被引:9
|
作者
Ouaalaya, El Hassane [1 ]
Falque, Laurent [3 ]
Dupis, Jean Michel [4 ]
Sabatini, Marielle [5 ]
Bernady, Alain [6 ]
Nguyen, Laurent [7 ]
Ozier, Annaig [7 ]
Nocent-Ejnaini, Cecilia [5 ]
Le Guillou, Frederic [8 ]
Molimard, Mathieu [9 ]
Zysman, Maeva [10 ]
Raherison-Semjen, Chantal [1 ,2 ]
机构
[1] Bordeaux Univ, Bordeaux Populat Hlth Res Ctr, UMR1219, Team EPICENE,INSERM, Bordeaux, France
[2] CHU Bordeaux, Pole Cardiothorac, Resp Dis Dept, Bordeaux, France
[3] Polyclin Bordeaux Rive Droite, Lormont, France
[4] Cabinet Med Pessac, Pessac, France
[5] CHG Cote Basque, Bayonne, France
[6] Med Ctr TOKI EDER, Cambo Les Bains, France
[7] Polyclin St Augustin, Bordeaux, France
[8] Cabinet Med, La Rochelle, France
[9] Bordeaux Univ, Bordeaux Populat Hlth Res Ctr, Team Pharmacoepidemiol, INSERM,UMR 1219, Bordeaux, France
[10] Bordeaux Univ, Cardiothorac Res Ctr Bordeaux, UMR1045, Team 2,INSERM, Bordeaux, France
关键词
COPD Phenotypes; Frequent exacerbator; Cluster analysis; Longitudinal analysis; OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; INFLUENZA VACCINATION; HOSPITALIZATION; FLUTICASONE; PREVENTION; MORTALITY;
D O I
10.1016/j.rmed.2020.106018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Exacerbations are key events in the natural history of COPD, but our understanding of their longitudinal determinants remains unclear. We used data from a large observational study to test the hypothesis that vaccination status and comorbidities could be associated with the occurrence of exacerbations profile. Methods: Diagnosed COPD patients have been included by their pulmonologists, with up to 3 years of follow-up. Data were analyzed using the KmL method designed to cluster longitudinal data and receiver operating characteristic curve analysis to determine the best threshold to allocate patients to identified clusters. Results: 932 COPD patients were included since January 2014, 446 patients (65.68% males, 35.59% current smokers) were followed over a period of 3 years with complete data. 239(28.15%) patients reported two or more exacerbations in the year before enrolment (frequent exacerbations). Among them 142(16.68%) also had frequent exacerbations in the first year of the study, and 69(8.10%) who remained frequent exacerbators in the second year. Based on our hypothesis, we were able to determine four phenotypes: A (infrequent), B (frequent in underweight patients), C (transient), and D (frequent in obese patients). Frequent exacerbators had more airflow limitation and symptoms. Irrespective of cut-offs set to define the optimal number of clusters, a history of exacerbations OR: 3.72[2.53-5.49], presence of anxiety OR: 2.03[1.24-3.31] and absence of the annual influenza vaccination OR: 1.97[1.20-3.24] remained associated with the frequent exacerbator phenotypes. Conclusions: The most important determinants of frequent exacerbations are a history of exacerbations, anxiety and unvaccinated against influenza.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients
    Andrei Malinovschi
    Monica Masoero
    Michela Bellocchia
    Antonio Ciuffreda
    Paolo Solidoro
    Alessio Mattei
    Lorena Mercante
    Enrico Heffler
    Giovanni Rolla
    Caterina Bucca
    Respiratory Research, 15
  • [42] Systemic effect of continuous treatment with azithromycyn in patients with severe COPD and frequent exacerbations
    Cuevas Sales, Ester
    Huertas Almela, Daniel
    Pascual Gonzalezi, Yuliana
    Lopez Sanchez, Marta
    Monton Soler, Concepcion
    Pomares Amigo, Xavier
    Marin Tapia, Alicia
    Garcia Nunez, Marian
    Marti Marti, Sara
    Santos Perez, Salud
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [43] HEALTHCARE RESOURCE UTILIZATION AND COSTS IN OLDER COPD PATIENTS WITH AND WITHOUT FREQUENT EXACERBATIONS
    Le, T.
    Fleming, S.
    Aynalem, A.
    Chen, J.
    Le, Y.
    Simoni-Wastila, L.
    VALUE IN HEALTH, 2020, 23 : S350 - S350
  • [44] Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations
    Pascual, Sergi
    Puigdevall, Pau
    Casadevall, Carme
    Barreiro, Esther
    Castelo, Robert
    Gea Guiral, Joaquim
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients
    Malinovschi, Andrei
    Masoero, Monica
    Bellocchia, Michela
    Ciuffreda, Antonio
    Solidoro, Paolo
    Mattei, Alessio
    Mercante, Lorena
    Heffler, Enrico
    Rolla, Giovanni
    Bucca, Caterina
    RESPIRATORY RESEARCH, 2014, 15 : 1 - 8
  • [46] Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
    McCullagh, Brian N.
    Comellas, Alejandro P.
    Ballas, Zuhair K.
    Newell, John D., Jr.
    Zimmerman, Bridget
    Azar, Antoine E.
    PLOS ONE, 2017, 12 (02):
  • [47] Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
    Pitassi, Manuela
    Vitale, Carolina
    D'Amato, Maria
    Stanziola, Anna
    Mormile, Mauro
    Molino, Antonio
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [48] Impact of moderate and severe exacerbations in severe COPD patients
    Gunsoy, Necdet B.
    Pascoe, Katie
    Asukai, Yumi
    Gait, Claire
    Galkin, Dmitry
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [49] EVALUATION AND IMPACT OF FRAILTY IN PATIENTS WITH ACUTE EXACERBATIONS OF COPD
    Osadnik, C.
    Kavanagh, A.
    Macdonald, M.
    Tran, A.
    Bardin, P.
    Haines, T.
    RESPIROLOGY, 2019, 24 : 126 - 126
  • [50] Frequent Productive Cough in COPD Patients Without Exacerbation History Is Associated With Increased Risk of Exacerbations and a Treatment Benefit From Budesonide/Glycopyrrolate/Formoterol Fumarate: A Post Hoc Analysis of Kronos
    Marshall, J.
    Martinez, F. J.
    Ferguson, G. T.
    Mushunje, A.
    Bowen, K.
    Jenkins, M.
    Patel, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209